Arthur Tzianabos - Insider Trading & Ownership

Entity
Individual
Location
C/O Homology Medicines, Inc., One Patriots Park, Bedford, Massachusetts
Summary
The estimated net worth of Arthur Tzianabos is at least $154 K dollars as of June 7, 2024. Arthur Tzianabos is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (FIXX) stock worth about $84.7 K. Arthur Tzianabos is the Director of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $69.5 K.
All Insider Reports
All Insider Reports

Ownership of Arthur Tzianabos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FIXX Q32 Bio Inc. Director $84.7 K -$7.45 K -8.08% Mar 25, 2024
STOK Stoke Therapeutics, Inc. Director $69.5 K Jun 5, 2024
AKUS Akouos, Inc. Director Nov 30, 2022

Insider Transactions Reported by Arthur Tzianabos:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership